TASMAR Safety Questions, TASMAR Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about TASMAR. Our extensive database of TASMAR adverse events and TASMAR warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about TASMAR
TASMAR Safety Reports
Total TASMAR reports: 24.TASMAR FDA safety alerts: No.
Reported deaths: 10 Reported hospitalizations: 4.
Take TASMAR Side Effects Survey or Share Your TASMAR Story. TASMAR Usage.
Consumer or non-health professional from IRELAND reported TASMAR problem on Nov 02, 2006. Female patient, 61 years of age, was diagnosed with parkinson's disease and was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: hepatitis. TASMAR dosage: 100 MG, PO. During the same period patient was treated with MADOPAR, PRAMIPEXOLE DIHYDROCHLORIDE, SINEMET CR. Patient recovered.
TASMAR problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 21, 2006. Female patient, 70 years of age, weighting 154.1 lb, was diagnosed with parkinson's disease and was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, lung neoplasm malignant. TASMAR dosage: 100 MG, TID;. During the same period patient was treated with PROPRANOLOL, CLONAZEPAM, ZOPICLONE, CLEXANE. Patient recovered.
Physician from GERMANY reported TASMAR problem on Dec 29, 2006. Female patient, 80 years of age, was diagnosed with parkinson's disease and was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: aggression, agitation, arrhythmia, atrial fibrillation, cardiomegaly, cerebral atrophy, dementia, disturbance in attention. TASMAR dosage: unknown. During the same period patient was treated with CANDESARTAN, BISOPROLOL, ACETYLSALICYLIC ACID SRT, CARBIDOPA, LEVODOPA, AMANTADINE. Patient died.
TASMAR problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 26, 2007. Female patient, 68 years of age, weighting 117.9 lb, was diagnosed with parkinson's disease and was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, fall, hepatic enzyme increased, influenza, nausea, parkinson's disease, vomiting. TASMAR dosage: 100 MG; TID; PO. During the same period patient was treated with PROPRANOLOL, DOMPERIDONE, CARBIDOPA. Patient recovered.
Physician from GERMANY reported TASMAR problem on Mar 06, 2007. Male patient, 80 years of age, was diagnosed with parkinsonism and was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: anaemia, blood creatine phosphokinase increased, compartment syndrome, deep vein thrombosis, hepatic enzyme increased, multi-organ failure, myocardial infarction. TASMAR dosage: unknown. During the same period patient was treated with ISOCOM, SIFROL, TRAZODONE, SEROQUEL, AMANTADINE. Patient was hospitalized. Patient died on 01/27/2007.
TASMAR problem was reported by a Physician from GERMANY on Mar 13, 2007. Male patient, 80 years of age, was diagnosed with parkinsonism and was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: acute hepatic failure, anaemia, blood creatine phosphokinase increased, cardiovascular disorder, coagulopathy, compartment syndrome, deep vein thrombosis, factor v leiden mutation, multi-organ failure. TASMAR dosage: unknown. During the same period patient was treated with ISOCOM, SIFROL, TRAZODONE, SEROQUEL. Patient was hospitalized. Patient died on 01/27/2007.
Consumer or non-health professional from UNITED KINGDOM reported TASMAR problem on Mar 30, 2007. Male patient, 68 years of age, weighting 240.3 lb, was diagnosed with parkinson's disease and was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, chronic obstructive pulmonary disease. TASMAR dosage: unknown. During the same period patient was treated with MADOPAR, BUMETANIDE, ATORVASTATIN CALCIUM, PARACETAMOL, ENTACAPONE, PRAMIPEXOLE DIHYDROCHLORIDE, RASAGILINE MESILATE. Patient died on 02/19/2007.
TASMAR problem was reported by a Physician from GERMANY on Apr 03, 2007. Male patient, 80 years of age, weighting 138.9 lb, was diagnosed with parkinsonism and was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: anaemia, compartment syndrome, condition aggravated, deep vein thrombosis, haemorrhage, hepatic failure, international normalised ratio increased, multi-organ failure, myocardial infarction. TASMAR dosage: 100 MG;TID; PO. During the same period patient was treated with ISOCOM, SIFROL, TRAZODONE, SEROQUEL, CARBIDOPA. Patient was hospitalized. Patient died on 01/27/2007.
Health Professional from CANADA reported TASMAR problem on Apr 30, 2007. Female patient, 75 years of age, weighting 114.6 lb, was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, liver function test abnormal. TASMAR dosage: 10 MG; TID; PO. During the same period patient was treated with SINEMET, PERMAX, AMANTADINE, EXELON, DOMPERIDONE, TYLENOL W, AMOXICLAV. Patient recovered.
TASMAR problem was reported by a Physician from UNITED STATES on May 17, 2007. Male patient was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: agitation, depression, dysarthria, fall, hallucination, homicidal ideation, muscular weakness, suicidal ideation, tremor. TASMAR dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported TASMAR problem on May 29, 2007. Male patient was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased. TASMAR dosage: 100 MG;TID;. During the same period patient was treated with LEVODOPA, MIRAPIXINE. Patient recovered.
TASMAR problem was reported by a Physician from UNITED KINGDOM on June 26, 2006. Male patient, 65 years of age, weighting 138.9 lb, was diagnosed with parkinson's disease and was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased. TASMAR dosage: 300 MG;QD;PO. During the same period patient was treated with AMITRIPTYLINE, APOMORPHINE, ASPIRIN, MADOPAR. Patient recovered.
Health Professional from UNITED KINGDOM reported TASMAR problem on July 21, 2006. Male patient, 65 years of age, weighting 138.9 lb, was diagnosed with parkinson's disease and was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased. TASMAR dosage: 300 MG; QD; PO. During the same period patient was treated with AMITRIPTYLINE, APOMORPHINE, ASPIRIN, MADOPAR. Patient recovered.
TASMAR problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 01, 2006. Female patient, 68 years of age, weighting 117.9 lb, was diagnosed with parkinson's disease and was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: hepatic failure. TASMAR dosage: 100 MG; TID; PO. During the same period patient was treated with PROPRANOLOL, DOMPERIDONE, CARBIDOPA. Patient recovered.
Physician from UNITED KINGDOM reported TASMAR problem on Aug 25, 2006. Male patient, 65 years of age, weighting 138.9 lb, was diagnosed with parkinson's disease and was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased. TASMAR dosage: 100 MG; TID; PO. During the same period patient was treated with MADOPAR, AMITRIPTYLINE, APOMORPHINE, SALICYLIC ACID, ENTACAPONE. Patient recovered.
TASMAR problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 30, 2006. Female patient, 68 years of age, weighting 117.9 lb, was diagnosed with parkinson's disease and was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, condition aggravated, fall, hepatic enzyme increased, hepatic failure, influenza, malaise, parkinson's disease. TASMAR dosage: 100 MG TID PO. During the same period patient was treated with PROPRANOLOL, DOMPERIDONE, CARBIDOPA. Patient recovered.
Physician from UNITED KINGDOM reported TASMAR problem on May 15, 2007. Female patient, 68 years of age, weighting 117.9 lb, was diagnosed with parkinson's disease and was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: condition aggravated, contusion, fall, hepatic failure, parkinson's disease. TASMAR dosage: 100 MG; TID; PO; 100 MG; QD; PO. During the same period patient was treated with PROPRANOLOL, DOMPERIDONE, CARBIDOPA. Patient recovered.
TASMAR problem was reported by a Physician from CANADA on May 11, 2006. Female patient, 59 years of age, was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: respiratory distress. TASMAR dosage: 100 MG; TID; PO. During the same period patient was treated with SINEMET. Patient died.
Physician from CANADA reported TASMAR problem on May 11, 2006. Female patient, 74 years of age, was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: antinuclear antibody positive, biliary cirrhosis, blood fibrinogen decreased, blood glucose increased, blood iron increased, blood lactate dehydrogenase increased, blood urea increased, depressed level of consciousness, diarrhoea. TASMAR dosage: 300 MG; QD; PO. During the same period patient was treated with IBUPROFEN, TYLENOL NO, ARTANE, PROVERA, PERMAX, PREMARIN, ASPIRIN, SINEMET. Patient died.
TASMAR problem was reported by a Physician from CANADA on May 11, 2006. Female patient was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: muscle rigidity, parkinsonism. TASMAR dosage: unknown. Patient recovered.
Physician from CANADA reported TASMAR problem on May 11, 2006. Female patient, 82 years of age, was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. TASMAR dosage: 100 MG; TID; PO. Patient died.
TASMAR problem was reported by a Physician from CANADA on May 11, 2006. Male patient, 81 years of age, was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: pneumonia. TASMAR dosage: 100 MG; TID; PO. Patient died.
Physician from CANADA reported TASMAR problem on May 11, 2006. Male patient, 58 years of age, was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: pulmonary oedema. TASMAR dosage: 200 MG; TID; PO. During the same period patient was treated with SINEMET, BROMOCRIPTINE MESYLATE, AMANTADINE. Patient died.
TASMAR problem was reported by a Consumer or non-health professional from FRANCE on Aug 30, 2007. Female patient, 47 years of age, was diagnosed with parkinson's disease and was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: parkinsonism, rash erythematous. TASMAR dosage: unknown. During the same period patient was treated with MADOPAR, COZAAR. Patient was hospitalized. Patient recovered.